socalTECH

OCTOBER 11, 2012

Calabasas-based KYTHERA Biopharmaceuticals , a developer of aesthetic medicine products aimed at reducing fat deposits, has priced its IPO at $16.00 The firm priced at the high end of its estimated initial public offering range, which was between $14.00 and $16.00 per share.

Pricing 124

Pricing Calabasas Marketing Product 124

socalTECH

SEPTEMBER 26, 2012

Calabasas-based KYTHERA Biopharmaceuticals , a venture-backed developer of aesthetic medicine products, has set its IPO pricing range, saying earlier this week that it is expectings its IPO price to be between $14.00 and $16.00 KYTHERA is looking to list on the NASDAQ Global Market as KYTH. READ MORE>>.

Pricing 133

Pricing Calabasas Marketing Product 133

socalTECH

SEPTEMBER 20, 2016

Calabasas-based audio technology developer DTS is being acquired by San Jose-based Tessera Technologies , in a deal worth approximately $850M in cash, the companies announced today. per share in cash, which is a 28 percent premium to the 30-day volume weighted average price of DTS. READ MORE>>.

Technology 100

Technology Calabasas Acquisition Pricing 100

socalTECH

JANUARY 30, 2017

Calabasas-based network testing software and hardware developer Ixia has been acquired by Keysight Technologies , in a deal worth $1.6 per share in cash for Ixia, a premium of approximately 45 percent to Ixia's stock price on December 1st, when Ixia said it was considering "strategic alternatives".

Calabasas 100

Calabasas Pricing Networking Software 100

socalTECH

APRIL 17, 2012

Santa Ana-based SRS Labs , the developer of audio processing and enhancement technology, is being acquired by fellow audio processing firm DTS , in a deal worth approximately $148M, the firms said this morning. SRS and Calabasas-based DTS said that DTS will pay cash and stock valued at $9.50

Calabasas 145

Calabasas Pricing Technology Develop 145